FdaApplication

ANDA 214329

Back to search

Identifiers

Properties

PropertyValue
applicant_namePHARMAZONE
application_typeANDA
approval_date2021-07-28

Products (1)

ProductActive ingredientStrengthDosage form
URSODIOLURSODIOL300MGCAPSULE;ORAL

1 product